Table 3.
Visfatin levels and glutathione peroxidase activity based on sex and age in non-metabolic syndrome and metabolic syndrome (with three components, with > 3 components of metabolic syndrome) groups
| Variable | Non-metabolic syndrome (n = 45) | Metabolic syndrome with three components (n = 29) | Metabolic syndrome with > 3 components (n = 16) | P |
|---|---|---|---|---|
| Visfatin (mg/ml) | ||||
| Sex | ||||
| Female (n = 49) | 2.80 ± 3.51 | 1.70 ± 1.10 | 3.14 ± 2.41 | 0.206 |
| Male (n = 41) | 2.85 ± 2.17 | 4.33 ± 5.12 | 3.00 ± 1.76 | 0.841 |
| P | 0.435 | 0.022 | 0.842 | |
| Age | ||||
| 19-45 year (n = 56) | 2.93 ± 3.29 | 3.11 ± 4.52 | 2.80 ± 2.94 | 0.963 |
| > 45 year (n = 34) | 2.40 ± 2.09 | 2.73 ± 2.84 | 3.16 ± 1.58 | 0.277 |
| P | 0.716 | 0.968 | 0.389 | |
| Peroxidase activity (mU/ml) | ||||
| Sex | ||||
| Female (n = 49) | 20.46 ± 35.35** | 1.64 ± 1.53* | 12.57 ± 28.89 | 0.043 |
| Male (n = 41) | 23.71 ± 41.90 | 4.21 ± 6.80 | 14.23 ± 30.76 | 0.376 |
| P | 0.314 | 0.060 | 0.272 | |
| Age | ||||
| 19-45 year (n = 56) | 22.91 ± 37.80 | 3.72 ± 6.58 £ | 43.06 ± 45.31** | 0.022 |
| > 45 year (n = 34) | 16.62 ± 37.38 | 1.90 ± 1.24 | 2.03 ± 1.67 | 0.102 |
| P | 0.598 | 0.853 | 0.005 |
The results are expressed as mean values ± standard deviation (SD); P-values are significant P < 0.05; Kruskal-Wallis test and Mann-Whitney tests (for multiple comparison) was used;
Significant difference with non-MetS;
Significant difference with MetS with three components or with hyperglycemia;
Significant difference with MetS with > 3 components or without hyperglycemia